OAM
ACHV icon

Oxford Asset Management’s Achieve Life Sciences ACHV Stock Holding History

Oxford Asset Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-17
Closed -$25K – 782
2016
Q1 		$25K Buy
+17
New +$27.7K ﹤0.01% 780
2014
Q2 		– Sell
-12
Closed -$317K – 680
2014
Q1 		$317K Buy
+12
New +$295K 0.01% 562

Other funds holding ACHV

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oxford Asset Management's ACHV Position: Q2 2016 in Review

Oxford Asset Management sold out of Achieve Life Sciences (ACHV) in Q2 2016, closing a stake of 17 shares — an estimated $25K sold.

Oxford Asset Management first reported a position in ACHV in Q1 2014 and held it in 2 quarters. The position peaked at $317K in Q1 2014. 34 funds tracked by Wall St. Rank hold ACHV as of Q2 2016.

  • Oxford Asset Management reported no remaining Achieve Life Sciences position as of Q2 2016 after selling out during the quarter.
  • Oxford Asset Management sold 17 Achieve Life Sciences shares in Q2 2016, an estimated $25K.
  • Oxford Asset Management first reported a position in Achieve Life Sciences in Q1 2014 and held it in 2 quarters.
  • Oxford Asset Management's Achieve Life Sciences position peaked at $317K in Q1 2014.
  • 34 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2016.

Based on Oxford Asset Management's 13F filing for Q2 2016, filed 8 Aug 2016.